companydata.dkcompanydata.dk

Freya Biosciences License ApS: Financial statements 2022

CVR: 41372079

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Freya Biosciences License ApS (CVR 41372079) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -48,000 and a net result of DKK -48,000 compared with DKK -37,500 the year before. Equity in the 2022 report amounted to DKK 105,000. The solvency ratio was 61%.

Gross Profit
DKK -48,000
Profit/Loss
DKK -48,000
Equity
DKK 105,000
Total Assets
DKK 172,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--48K-48K105K-
20210-38K-38K19K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Freya Biosciences License ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Freya Biosciences License ApS: The 2021 annual report is outOct 28, 2022

Freya Biosciences License ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -37,500.

Peter Finsel Bisgaard joins the board of Freya Biosciences License ApSOct 7, 2022

As of October 7, 2022, Peter Finsel Bisgaard has joined the board of directors of Freya Biosciences License ApS.

Henrijette Elsebeth Richter joins the board of Freya Biosciences License ApSOct 7, 2022

As of October 7, 2022, Henrijette Elsebeth Richter has joined the board of directors of Freya Biosciences License ApS.

Colleen Denise Acosta joins the board of Freya Biosciences License ApSOct 7, 2022

As of October 7, 2022, Colleen Denise Acosta has joined the board of directors of Freya Biosciences License ApS.

Mark Smith joins the board of Freya Biosciences License ApSOct 7, 2022

As of October 7, 2022, Mark Smith has joined the board of directors of Freya Biosciences License ApS.

Nicholas Haft joins the board of Freya Biosciences License ApSOct 7, 2022

As of October 7, 2022, Nicholas Haft has joined the board of directors of Freya Biosciences License ApS.

Colleen Denise Acosta joins Freya Biosciences License ApS as adm. dir.Oct 7, 2022

As of October 7, 2022, Colleen Denise Acosta is registered as adm. dir. of Freya Biosciences License ApS.

Lars Skanvig Bramhelft steps down as liquidator of Freya Biosciences License ApSOct 7, 2022

As of October 7, 2022, Lars Skanvig Bramhelft has stepped down as liquidator of Freya Biosciences License ApS.

Freya Biosciences License ApS exits liquidationOct 7, 2022

On October 7, 2022, Freya Biosciences License ApS exited liquidation.

Lars Skanvig Bramhelft joins Freya Biosciences License ApS as liquidatorSep 12, 2022

As of September 12, 2022, Lars Skanvig Bramhelft is registered as liquidator of Freya Biosciences License ApS.

About Freya Biosciences License ApS

Freya Biosciences License ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Colleen Denise Acosta. The board consists of Peter Finsel Bisgaard (chair), Claudia Maria Colciago, Colleen Denise Acosta and David Lawrence Stern. The company's owners include Danmarks Eksport- og Investeringsfond, OMX Ventures Fund I, LLC and Sofinnova Capital IX. In 2025, the company reported a gross profit of DKK -14,000 and a net result of DKK -14,000 compared with DKK -30,358 the year before. Equity in the 2025 report amounted to DKK 357,000.

Source: annual report 2025, Danish Business Authority

Other financial years